Earliest US filing for COVID vaccine would be late November: Pfizer Ruchika Sharma19 Oct 2020 11:00 AM ISTNew York: Pfizer Inc said on Friday it could file in late November for US authorization of the COVID-19 vaccine it is developing, suggesting that a...
Pfizer-BioNTech COVID vaccine trial remains on track, says CEO Ruchika Sharma18 Oct 2020 10:00 AM ISTNew Delhi: Side effects that have emerged in a large late-stage trial of a Covid-19 vaccine candidate from Pfizer Inc. and BioNTech SE are in line...
Pfizer, BioNTech ink deal with New Zealand for COVID-19 vaccine Ruchika Sharma15 Oct 2020 9:00 AM ISTSydney: The New Zealand government signed a deal on Monday to buy 1.5 million COVID-19 vaccines from Pfizer Inc and Germany's BioNTech, with delivery...
Pfizer modifies Covid vaccine study protocol to include adolescents Farhat Nasim14 Oct 2020 1:22 PM ISTPfizer stated that it received permission from the Food and Drug Administration to include adolescents aged 12 through 15 in its global Covid-19...
Pfizer breast cancer drug fails to meet primary endpoint Ruchika Sharma11 Oct 2020 10:15 AM ISTNeu-Isenburg & Frankfurt & New York: The German Breast Group (GBG) and Pfizer Inc. have recently announced that the collaborative...
India needs ramping up cold chain facilities for safe delivery of COVID vaccines, says Experts Ruchika Sharma11 Oct 2020 10:00 AM ISTNew Delhi: The safe delivery of vaccines for mass immunisation against Covid-19 is a massive challenge and India will need to significantly ramp up...
Pfizer arthritis drug Xeljanz gets USFDA okay Ruchika Sharma2 Oct 2020 10:00 AM ISTNew York: Pfizer Inc. has recently announced that the United States (U.S.) Food and Drug Administration (FDA) has approved...
BioNTech acquires Novartis site to boost COVID vaccine production Ruchika Sharma18 Sept 2020 12:11 PM ISTThe facility in Marburg will be converted to be fully on stream in the first half of 2021 with an annual production capacity up to 750 million doses...
Mylan, Pfizer gets European Commission nod for Upjohn business Ruchika Sharma17 Sept 2020 11:00 AM ISTHertfordshire, Pittsburgh and New York: Mylan and Pfizer Inc. have recently announced that the companies have received final approval from the...
Pfizer, BioNTech eye expansion of COVID-19 vaccine trial to 44000 volunteers Ruchika Sharma15 Sept 2020 11:00 AM ISTNew York & Mainz, Germany: Pfizer Inc. and BioNTech SE have recently announced that they have submitted an amended protocol to the U.S....
Pfizer, BioNTech begin German part of COVID vaccine study Medical Dialogues Bureau13 Sept 2020 9:00 AM ISTGermany's vaccines regulator, the Paul Ehrlich Institute, gave the approval for the Phase 2/3 trial of the experimental vaccine known as BNT162b2,...
COVID-19: Pharma firms sign vaccine safety pledge MD Bureau9 Sept 2020 1:45 PM ISTThe CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer and Sanofi have signed the pledge.
